COCIR backs EU medtech soft/hardware patents move:
This article was originally published in Clinica
Executive Summary
The European electromedical equipment industry association, COCIR, says that it supports the adoption of an EU directive on Computer Implemented Inventions (CIIs). The aim of the directive would be to harmonise rules for patents on such inventions, granting patents on CIIs, but not on individual pieces of software. CIIs, COCIR explains, are a defined combination of hard and software which make a genuine contribution of their own and innovative medical equipment is increasingly dependent on CIIs. The directive would define under which conditions patents could be granted, thus defining a clear relationship between inventors and users of the invention.
You may also be interested in...
Simplified Clinical Trial Transparency Rules To Go Live In The EU In June
A new version of the EU Clinical Trials Information System’s public portal will integrate the functionalities of the streamlined transparency rules.
Top-Selling Drugs 2023: Pharma’s $60bn COVID-19 Cliff
Pfizer/BioNTech’s COVID-19 vaccine Comirnaty toppled after recording the highest ever annual sales for a pharmaceutical in 2022, while Novo Nordisk’s Ozempic climbed rapidly. But Merck & Co’s immuno-oncology blockbuster Keytruda was secure in the number one spot in 2023 as COVID-19 receded.
Changes To EU Pharma Reform: More Questions Than Answers?
In the first of a series of articles on the future direction of the EU pharmaceutical reform proposals, the Pink Sheet looks at the new uncertainties created for the drug industry after the European Parliament voted through a series of amendments in the area of regulatory data protection.